Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study is aimed at assessing the effectiveness of a novel liver specific nerve block in
improving pain control during painful liver interventional radiology procedures including
liver tumoral ablation and trans arterial chemoembolization, two procedures aimed at
controlling liver tumors, but that can be associated with significant pain. This novel
hepatic specific nerve block was designed by us and initial retrospective results suggests it
might help in controlling such liver procedural derived pain. The study was designed to
compare the liver block to a sham procedure in a blinded context and to follow the
participants over three days post-procedure to asses for pain levels.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre